Information  X 
Enter a valid email address
  Print          More announcements

Friday 01 May, 2020

Morgan Stanley Cap

Rule 38.5 - Replacement of ABBVIE INC.

RNS Number : 7004L
Morgan Stanley Capital Services LLC
01 May 2020
 

AMENDMENT Section (2b)

 

  FORM 38.5

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)

 

DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS

 

1.  KEY INFORMATION

 Name of exempt market-maker

  Morgan Stanley Capital Services LLC

 Company dealt in

  ABBVIE INC.

 Class of relevant security to which the dealings being disclosed relate (Note 1)

  US$0.01 COMMON STOCK

 Date of dealing

  29 APRIL 2020

 

 

2.  DEALINGS  (Note 2)

 

(a)  Purchases and sales

 Total number of relevant secuities accquired

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

   129,674

 84.4900 USD

 82.1600 USD

 

 Total number of relevant secuities disposed

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

   145,559

 84.7300 USD

 82.6600 USD

 

 

(b)  Derivatives transactions (other than options transactions)

 

 Product name, e.g. CFD

 Nature of transaction

  (Note 4)

 Number of relevant securities

  (Note 5)

 Price per unit

 CFD

 LONG

 40

 82.9400 USD

 CFD

 LONG

 3,100

 83.7987 USD

 CFD

 LONG

 13,700

 83.8889 USD

 CFD

 LONG

 4,925

 84.0046 USD

 CFD

 LONG

 22,516

 84.0046 USD

 CFD

 LONG

 1,100

 84.0127 USD

 CFD

 SHORT

 480

 82.8661 USD

 CFD

 SHORT

 1,144

 82.8661 USD

 CFD

 SHORT

 9,841

 83.7600 USD

 CFD

 SHORT

 434

 83.7600 USD

 CFD

 SHORT

 300

 83.7916 USD

 CFD

 SHORT

 200

 83.7916 USD

 CFD

 SHORT

 100

 83.7916 USD

 CFD

 SHORT

 500

 83.7916 USD

 CFD

 SHORT

 100

 83.7916 USD

 CFD

 SHORT

 126

 83.8713 USD

 CFD

 SHORT

 111

 83.8714 USD

 CFD

 SHORT

 87

 83.9300 USD

 CFD

 SHORT

 141

 84.0284 USD

 CFD

 SHORT

 17

 84.0400 USD

 CFD

 SHORT

 78

 84.4899 USD

 

 

(c)  Options transactions in respect of existing relevant securities

 

i)  Writing, selling, purchasing or varying

 

 Product name, eg call option

 Writing, selling, purchasing, varying etc

 Number of securities to which the option relates (Note 5)

 Exercise Price

 Type, e.g American, European etc

 Expiry Date

 Option money paid/received per unit (Note 3)

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 

(ii) Exercising

 

 Product name, eg call option

 Number of securities

 Exercise price per unit (Note 3)

 N/A

 N/A

 N/A 

 

 

3. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 Date of disclosure

 01 MAY 2020

 Contact Name

Craig Horsley

 Telephone Number

+44(141) 245 7736

 Name of offeree/offeror with which connected

ABBVIE INC.

Nature of connection (Note 6)

Advisory

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEBDGDULUGDGGB

a d v e r t i s e m e n t